On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
January 5, 2018
Attention Physicians: If you plan to continue to be a Medical Director for a Florida MMTC, click here for more information. Continue reading
November 3, 2017
Chronic Disease Prevention: A Public Health Perspective. Please click for details on how to register for this webinar. Continue reading